Total Payments
$11,305
2024 Payments
$0
Companies
30
Transactions
227
Medicare Patients
9,612
Medicare Billing
$648,037
Payment Breakdown by Category
Other$6,745 (59.7%)
Food & Beverage$3,369 (29.8%)
Travel$839.54 (7.4%)
Education$351.59 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,745 | 3 | 59.7% |
| Food and Beverage | $3,369 | 208 | 29.8% |
| Travel and Lodging | $839.54 | 2 | 7.4% |
| Education | $351.59 | 5 | 3.1% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$11,305
218 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $8,886 | 66 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $527.82 | 41 | $0 (2020) |
| Dendreon Pharmaceuticals LLC | $384.81 | 25 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $240.98 | 12 | $0 (2023) |
| PFIZER INC. | $204.00 | 6 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $172.01 | 9 | $0 (2022) |
| Rochester Medical Corporation | $143.40 | 15 | $0 (2018) |
| AbbVie, Inc. | $77.38 | 4 | $0 (2018) |
| Olympus America Inc. | $64.56 | 4 | $0 (2021) |
| Antares Pharma, Inc. | $63.39 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $0 | 2 | SN Holdings, LLC |
| 2023 | $46.70 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($46.70) |
| 2022 | $270.09 | 17 | Astellas Pharma US Inc ($118.18) |
| 2021 | $264.27 | 13 | Astellas Pharma US Inc ($99.00) |
| 2020 | $388.31 | 24 | Endo Pharmaceuticals Inc. ($121.05) |
| 2019 | $795.33 | 39 | Astellas Pharma US Inc ($228.03) |
| 2018 | $4,547 | 76 | Astellas Pharma US Inc ($3,819) |
| 2017 | $4,993 | 53 | Astellas Pharma US Inc ($4,532) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Oncology | ||||||
| 10/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Oncology | ||||||
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Oncology | ||||||
| 11/30/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Continence Care | ||||||
| 11/18/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Oncology | ||||||
| 11/09/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Prostate Cancer | ||||||
| 11/03/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Urology | ||||||
| 10/12/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Urology | ||||||
| 09/22/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Urology | ||||||
| 09/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Oncology | ||||||
| 08/01/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Urology | ||||||
| 07/22/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Oncology | ||||||
| 07/20/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Urology | ||||||
| 06/28/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Urology | ||||||
| 06/15/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Urology | ||||||
| 05/05/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Urology | ||||||
| 04/19/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Oncology | ||||||
| 02/09/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Continence Care | ||||||
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 11/22/2021 | Olympus America Inc. | URETERO-RENO VIDEOSCOPE (Device) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Urology Gynecology | ||||||
| 08/09/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 04/20/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Testosterone Replacement Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 363 | 385 | $64,248 | $20,738 |
| 2022 | 25 | 2,605 | 3,893 | $725,759 | $210,730 |
| 2021 | 29 | 3,077 | 3,864 | $711,509 | $197,261 |
| 2020 | 35 | 3,567 | 4,586 | $873,459 | $219,308 |
Total Patients
9,612
Total Services
12,728
Medicare Billing
$648,037
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 61 | 62 | $34,410 | $11,702 | 34.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 18 | 18 | $11,790 | $4,556 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $3,800 | $1,423 | 37.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 101 | $3,232 | $848.40 | 26.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 19 | 27 | $3,915 | $723.89 | 18.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 14 | $2,660 | $658.53 | 24.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 14 | $1,176 | $245.75 | 20.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 82 | 85 | $935.00 | $187.00 | 20.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 14 | $980.00 | $156.24 | 15.9% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 15 | 15 | $525.00 | $118.65 | 22.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 14 | 15 | $825.00 | $118.44 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 396 | 572 | $154,440 | $50,461 | 32.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 164 | 189 | $104,895 | $33,359 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 504 | 550 | $104,500 | $32,911 | 31.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 108 | 691 | $58,044 | $31,825 | 54.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 23 | 187 | $161,820 | $25,482 | 15.7% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2022 | 12 | 14 | $25,830 | $8,734 | 33.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 186 | 245 | $17,150 | $4,334 | 25.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 34 | 34 | $12,919 | $3,763 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $15,170 | $3,426 | 22.6% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 11 | 11 | $9,240 | $3,336 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $10,260 | $2,713 | 26.4% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 11 | 11 | $3,630 | $1,783 | 49.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2022 | 52 | 70 | $5,250 | $1,743 | 33.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 458 | 548 | $6,028 | $1,214 | 20.1% |
About Dr. Lawrence Volz, M.D
Dr. Lawrence Volz, M.D is a Urology healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821076860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Volz, M.D has received a total of $11,305 in payments from pharmaceutical and medical device companies, with $0 received in 2024. These payments were reported across 227 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,745).
As a Medicare-enrolled provider, Volz has provided services to 9,612 Medicare beneficiaries, totaling 12,728 services with total Medicare billing of $648,037. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Williamsburg, VA
- Active Since 01/09/2006
- Last Updated 04/24/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1821076860
Products in Payments
- Myrbetriq (Drug) $4,351
- MYRBETRIQ (Drug) $3,989
- XIAFLEX (Biological) $519.22
- PROVENGE (Drug) $417.89
- XTANDI (Drug) $307.16
- ELIGARD (Drug) $172.01
- Xtandi (Drug) $154.92
- Nubeqa (Drug) $144.25
- Xofigo (Drug) $96.73
- MAGIC3 (Device) $94.51
- Androgel (Drug) $77.38
- SpeediCath (Device) $59.07
- Prolaris (Device) $46.61
- BOTOX (Biological) $38.04
- BMD-Magic3 Catheter (Device) $36.87
- ZYTIGA (Drug) $35.44
- UroLift (Device) $34.67
- OTREXUP (Drug) $31.81
- XYOSTED (Drug) $31.58
- Urgent PC (Device) $25.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.